Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Babler Martin Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2023 4 Babler Martin (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $0.79, valued at $19.8k
06/22/2022 4 Babler Martin (Director) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Granted 31,293 options to buy @ $4.74, valued at $148.3k
05/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2021 4 Babler Martin (Director) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Granted 36,400 options to buy @ $31.37, valued at $1.1M
07/20/2021 3 Babler Martin (Director) has filed a Form 3 on Prelude Therapeutics Inc
05/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/06/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
09/28/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/10/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
06/25/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/05/2020 4 Babler Martin (President, CEO) has filed a Form 4 on Principia Biopharma Inc.
Txns: Gifted 1,159 shares @ $0
Gifted 1,159 shares @ $0
Sold 2,085 shares @ $62.4476, valued at $130.2k
Sold 7,183 shares @ $63.2398, valued at $454.3k
Sold 5,432 shares @ $64.098, valued at $348.2k
Sold 300 shares @ $64.8267, valued at $19.4k
Granted 200,000 options to buy @ $67.31, valued at $13.5M
12/19/2019 4 Babler Martin (President, CEO) has filed a Form 4 on Principia Biopharma Inc.
Txns: Sold 5,840 shares @ $51.7983, valued at $302.5k
Sold 11,485 shares @ $52.8571, valued at $607.1k
Sold 6,661 shares @ $53.9429, valued at $359.3k
Sold 1,014 shares @ $54.355, valued at $55.1k
Sold 1,000 shares @ $52.7747, valued at $52.8k
Sold 2,205 shares @ $53.6926, valued at $118.4k
Sold 1,295 shares @ $54.2799, valued at $70.3k
03/08/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/20/2018 4 Babler Martin (CEO) has filed a Form 4 on Principia Biopharma Inc.
Txns: Converted 988 shares @ $0
Converted 240 shares @ $0
Converted 988 shares @ $0
Converted 240 shares @ $0
Converted 988 shares @ $0
Converted 240 shares @ $0
Converted 988 options to buy @ $0
Converted 988 options to buy @ $0
Converted 988 options to buy @ $0
Converted 240 preferred shares @ $0
Converted 240 preferred shares @ $0
09/13/2018 3 Babler Martin (CEO) has filed a Form 3 on Principia Biopharma Inc.
12/21/2015 4 Babler Martin (Director) has filed a Form 4 on ZS Pharma, Inc.
Txns: Disposed/sold 1,000 shares @ $90, valued at $90k
Disposed/sold 12,000 options to buy @ $46.86, valued at $562.3k
Disposed/sold 4,000 options to buy @ $55.57, valued at $222.3k
06/25/2015 4 Babler Martin (Director) has filed a Form 4 on ZS Pharma, Inc.
Txns: Granted 4,000 options to buy @ $55.57, valued at $222.3k
Granted 1,000 restricted stock units @ $0
06/13/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
05/18/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
05/19/2011 4 Babler Martin (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.
Txns: Granted 6,000 options to buy @ $6.8, valued at $40.8k
Granted 2,000 options to buy @ $6.8, valued at $13.6k
05/27/2010 4 Babler Martin (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.
Txns: Granted 5,625 options to buy @ $6.74, valued at $37.9k
Granted 1,875 options to buy @ $6.74, valued at $12.6k
06/19/2009 4 Babler Martin (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy